• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Bifurcation PCI -- KISS

  • Wed, 9/28/11 - 3:15pm
  • 1179 reads
  • 0 comments

A 52-year-old diabetic male presented with unstable angina. His risk factors included type II diabetes mellitus, hyperlipidemia, and tobacco use. He had undergone previous coronary bypass and had a patent mammary bypass and right coronary artery saphenous vein bypass. Previous Myoview stress test showed a large amount of lateral ischemia with maintained LV function (ejection fraction 63%). The patient had a tight calcific left main and proximal circumflex stenosis. Previous intervention was unsuccessful in recanalizing the left main and circumflex lesions adequate enough for placement of coronary stents. He presented for intervention with continued angina.

Recent data suggest that the Impella device allows one to more adequately atherectomize a long residual stenosis compared to simple intra-aortic balloon pump.1For this reason, we placed a J4 guide and the Impella device was placed via the contralateral groin. A wire was placed to protect the LAD even though it had been bypassed with an internal mammary bypass graft.

The patient presented 48 hours later with recurrence of angina. Because the concern was that we needed to do bifurcation intervention, the question of whether or not we should use the crush technique, double stenting technique, etc., came about.

Recently published papers suggest that a simple strategy is the wisest.2In fact, the simple strategy is more likely to result in less utilization of contrast, fluoroscopy with greater efficacy compared to complex techniques. Since it is unlikely we will have to place bifurcation balloons or stents, the radial technique using a 6 Fr catheter is ideal. We see the circumflex is widely patent and there appears to be 2 focal stenoses in the LAD, but again we were still concerned that we could inhibit competitive flow of the internal mammary by placing a stent.

This case demonstrated the utility of the Impella device for complete revascularization of a calcific functional occlusion, as well as using a simple strategy for a bifurcation lesion keeping into account the possibility of competitive filling of previously placed bypass grafts. The day after the procedure, the patient was discharged and continues to be asymptomatic 8 months after the procedure.

The simple bifurcation strategy again reiterates the safety and benefit of the radial approach for even complex interventions. Now that we know that the philosophy is to utilize the KISS technique, “keep it simple, stupid,” with bifurcation lesions, the radial technique is even more attractive.

Figure 1. Guiding catheter in place and the Impella across into the left ventricle.

 

 

 

Figure 2. This angiogram shows the severity of this circumflex, which was functionally occluded.

 

 

 

Figure 3. A Miracle 3 wire (Abbott Vascular) was placed in the circumflex and a Cougar wire (Medtronic) in the left anterior descending. A .9 Spectranetics laser probe passed across the circumflex stenosis and the AngioSculpt balloon further dilated the lesion. A second 2.5 mm AngioSculpt balloon was used in the LAD proximal stenosis.

 

Figure 4. Shows excellent results after laser and AngioSculpt dilation and subsequent placement of a 3.5mm Xience stent (Abbott). A second 2.5 mm AngioSculpt balloon was used to post dilate the LAD after recanalization of the circumflex.

 

 

Figure 5. This RAO view shows there is some diffuse distal circumflex disease, but the proximal vessel appears to be adequately dilated. The LAD, which again has an internal mammary, is patent. We did not place a stent at the origin of the LAD because of the possibility of competitive flow from the internal mammary artery.

 

Figure 6. This shows the vessel pre-intervention.

 

 

 

Figure 7. Utilizing for the radial technique, we have pre-dilated with a 3.0 AngioSculpt balloon into the LAD with 2 Cougar wires, one in the LAD and one in the circumflex.

 

 

Figure 8. In this RAO view, we see the vessel to be widely patent after placement of a 3.5 mm Xience stent.

 

 

 

Figure 9. In this LAO view, we see a residual ostial stenosis of perhaps 20% in the LAD, the widely patent circumflex and a tight stenosis in the LAD distal to the take-off of a large diagonal and septal branch. This stenosis in the LAD is revascularized by the internal mammary artery and most likely will not result in competitive filling with a possibility of compromise of this excellent graft.

 

 

 

References

1O’Neill W, Kleiman N, Henriques J, et al. PROTECT II, Prospective Multicenter Randomized Trial Comparing IMPELLA to IABP in High Risk PCI: 90 Day Results, on behalf of all PROTECT II Investigators. Presented at SCAI 2011.

2Behan M, Holm Niels, Curzen N, et al. Simplex or complex stenting for bifurcation coronary lesions. A patient-level pooled-analysis of the Nordic bifurcation study and the British bifurcation coronary study. Circ Cardiovasc Interv. 2011;4:57-64.

image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Tara Fields, Classified Sales Manager
    (800) 237-7285, ext. 259

vdm Blogs

EVAR found superior to Open AAA Repair for long-term survival in Medicare patients: Another nail in open surgery’s coffin?

Frank J Criado MD FACS FSVM

Aneurysms and Cancer: Which comes first in the endovascular era?

Ross Milner MD FACS

What is the best therapy when we compare current data for revascularization of the SFA?

Lawrence A. Garcia MD

When a Patient Presents with an Ulcer, Take a Careful History

Richard R. Heuser MD FACC FACP FESC FSCAI

Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies?

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
    Wed, 05/16/12 - 9:26am
  • Hospital Mortality Rates for Cardiovascular Revascularization Patients Varies Significantly by State
    Tue, 05/15/12 - 9:31am
  • Boston Scientific Announces CE Mark and European Launch of Innova Self-expanding Bare-metal Stent System
    Mon, 05/14/12 - 12:07pm
  • Self-Expanding and Balloon-Expandable Stent Systems Perform Well in Study of Real-World Peripheral Artery Disease Patients
    Fri, 05/11/12 - 11:06am
more »

Clinical Events Calendar

  • EuroPCR 2012
    Tue, 05/15/2012 - Fri, 05/18/2012
    Paris, France
  • International Vein Congress (IVC) 2012
    Thu, 05/31/2012 - Sun, 06/03/2012
    Miami Beach, FL, United States
  • New Cardiovascular Horizons (NCVH)
    Wed, 06/06/2012 - Sat, 06/09/2012
    New Orleans, LA, United States
more »

Poll

The current focus to decrease the profile size of aortic stent-grafts: :
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications